NASDAQ Composite ended the session with Amgen rising 1.72% to $252.53 on Wednesday while nASDAQ Composite rose 2.1% to $13,474.08.
Amgen today’s close was $252.53, 4.93% under its 52-week high of $264.97.
Amgen’s sales growth is 6.3% for the ongoing quarter and 3.1% for the next. The company’s growth estimates for the ongoing quarter is a negative 6.3% and positive 1% for the next.
Year-on-year quarterly revenue growth grew by 12%, now sitting on 24.99B for the twelve trailing months.
Amgen’s last day, last week, and last month’s average volatility was 1.13%, 0.89%, and 0.40%, respectively.
Amgen’s last day, last week, and last month’s high and low average amplitude percentage was 1.06%, 2.01%, and 2.03%, respectively.
Amgen’s Stock Yearly Top and Bottom Value
Amgen’s stock is valued at $252.53 at 17:17 EST, under its 52-week high of $264.97 and way higher than its 52-week low of $177.05.
Amgen’s Moving Average
Amgen’s worth is higher than its 50-day moving average of $230.48 and above its 200-day moving average of $238.72.